Characteristics of ST11 KPC-2-producing carbapenem-resistant hypervirulent Klebsiella pneumoniae causing nosocomial infection in a Chinese hospital

被引:13
作者
Ouyang, Pengwen [1 ]
Jiang, Bin [1 ]
Peng, Na [1 ]
Wang, Juan [2 ]
Cai, Liang [2 ]
Wu, Yi [1 ]
Ye, Jianrong [1 ]
Chen, Yiping [1 ]
Yuan, Hao [1 ]
Tan, Chaochao [1 ]
Tan, Liming [1 ]
Xie, Liangyi [1 ]
机构
[1] Hunan Normal Univ, Affiliated Hosp 1, Hunan Prov Peoples Hosp, Dept Clin Lab, Changsha 410005, Hunan, Peoples R China
[2] Ctr Dis Control & Prevent Hunan Prov, Dept Microbiol Lab, Changsha, Peoples R China
关键词
carbapenem resistance; hypervirulence; Klebsiella pneumoniae; nosocomial infection; MOLECULAR EPIDEMIOLOGY; VIRULENCE GENE; CAPSULAR TYPE; ENTEROBACTERIACEAE; PLASMIDS;
D O I
10.1002/jcla.24476
中图分类号
R446 [实验室诊断]; R-33 [实验医学、医学实验];
学科分类号
1001 ;
摘要
Background The purpose of our study is to analyze the microbiological and clinical characteristics of carbapenem-resistant hypervirulent Klebsiella pneumoniae (CR-hvKP) that causes nosocomial infection. Methods We collected the carbapenem-resistant K. pneumoniae (CRKP) strains that caused nosocomial infection in a hospital in China and collected the relevant clinical data. We characterized these strains for their antimicrobial and virulence-associated phenotype and genotype and analyzed the clonal relatedness. We screened hypervirulent strains and compared them with non-hypervirulent strains. Results We retrospectively analyzed 62 CRKP strains that caused nosocomial infection in a tertiary hospital within 1 year, of which 41 (41/62, 66.1%) CRKP were considered as CR-hvKP. All CR-hvKP strains were multi-drug resistance (MDR) and the vast majority of isolates (39/41, 95.1%) were ST11 KPC-2-producing strains. Two hypermucoviscous isolates and 4 capsular types were found in 41 CR-hvKP. Twenty-nine isolates (29/41, 70.7%) showed hypervirulence in Galleria mellonella infection model. PFGE showed that ST11-KL47 CR-hvKP and ST11-KL64 CR-hvKP exhibited a high degree of clonality, while non-hypervirulent strains were not significant. CR-hvKP had higher positive rates of bla(KPC-2) and bla(CTX-M-65) and higher levofloxacin resistance (p < 0.001, p = 0.005 and p = 0.046, respectively) when compared to the non-hypervirulent strains. There was no significant difference between the two groups in terms of in-hospital mortality (7/41, 17.1% vs 5/21, 23.8%, p = 0.743). Conclusion Our research finds that ST11 KPC-2-producing CR-hvKP is the main type of CRKP that caused nosocomial infection, and clonal spread has occurred. We provide more information about CR-hvKP in health care.
引用
收藏
页数:11
相关论文
共 35 条
[1]   wzi Gene Sequencing, a Rapid Method for Determination of Capsular Type for Klebsiella Strains [J].
Brisse, Sylvain ;
Passet, Virginie ;
Haugaard, Anita Bjork ;
Babosan, Anamaria ;
Kassis-Chikhani, Najiby ;
Struve, Carsten ;
Decre, Dominique .
JOURNAL OF CLINICAL MICROBIOLOGY, 2013, 51 (12) :4073-4078
[2]   Convergence of carbapenem-resistance and hypervirulence in Klebsiella pneumoniae [J].
Chen, Liang ;
Kreiswirth, Barry N. .
LANCET INFECTIOUS DISEASES, 2018, 18 (01) :2-3
[3]  
CLSI, 2016, Performance standards for antimicrobial susceptibility testing, V26th
[4]  
CLSI, 2018, PERFORMANCE STANDARD
[5]   Hypervirulent Klebsiella pneumoniae clones causing bacteraemia in adults in a teaching hospital in Barcelona, Spain (2007-2013) [J].
Cubero, M. ;
Grau, I. ;
Tubau, F. ;
Pallares, R. ;
Dominguez, M. A. ;
Linares, J. ;
Ardanuy, C. .
CLINICAL MICROBIOLOGY AND INFECTION, 2016, 22 (02) :154-160
[6]   Multilocus sequence typing of Klebsiella pneumoniae nosocomial isolates [J].
Diancourt, L ;
Passet, V ;
Verhoef, J ;
Grimont, PAD ;
Brisse, S .
JOURNAL OF CLINICAL MICROBIOLOGY, 2005, 43 (08) :4178-4182
[7]  
EUCAST, 2016, Breakpoint tables for interpretation of MICs and zone diameters. Version 11.0. 2021
[8]   A novel virulence gene in Klebsiella pneumoniae strains causing primary liver abscess and septic metastatic complications [J].
Fang, CT ;
Chuang, YP ;
Shun, CT ;
Chang, SC ;
Wang, JT .
JOURNAL OF EXPERIMENTAL MEDICINE, 2004, 199 (05) :697-705
[9]  
FDA, 2009, TYG TIG INJ
[10]  
Feng Y, 2018, ANTIMICROB AGENTS CH, V62, DOI [10.1128/AAC.02644-17, 10.1128/aac.02644-17]